Higgins Jack 4
4 · Immunome Inc. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Higgins Jack
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-10$1.35/sh+22,000$29,700→ 40,729 total - Exercise/Conversion
Employee Stock option (right to buy)
2025-09-10−22,000→ 151,840 totalExercise: $1.35Exp: 2032-06-23→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.